Does CILTACABTAGENE AUTOLEUCEL Cause Neurotoxicity? 140 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Neurotoxicity have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 3.7% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
140
Reports of Neurotoxicity with CILTACABTAGENE AUTOLEUCEL
3.7%
of all CILTACABTAGENE AUTOLEUCEL reports
41
Deaths
76
Hospitalizations
How Dangerous Is Neurotoxicity From CILTACABTAGENE AUTOLEUCEL?
Of the 140 reports, 41 (29.3%) resulted in death, 76 (54.3%) required hospitalization, and 9 (6.4%) were considered life-threatening.
Is Neurotoxicity Listed in the Official Label?
Yes, Neurotoxicity is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Death (130)
Malaise (126)
Fatigue (123)
Cranial nerve paralysis (115)
What Other Drugs Cause Neurotoxicity?
AXICABTAGENE CILOLEUCEL (1,327)
OXALIPLATIN (1,272)
METHOTREXATE (1,083)
CYCLOPHOSPHAMIDE (763)
FLUOROURACIL (735)
PACLITAXEL (734)
TACROLIMUS (623)
BEVACIZUMAB (588)
VINCRISTINE (555)
CAPECITABINE (553)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Neurotoxicity Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE